Treatment Strategies and Safety Updates in Multiple Sclerosis

MS treatment options have rapidly evolved. This activity will focus on research and recommendations to provide pharmacists short and long-term management strategies for patients with MS and help to ensure improved overall care coordination.

Update on Treatment of Moderate to Severe Asthma with Biologics

This activity will review the Global Initiative for Asthma (GINA) recommendations, describe type 2 inflammation in asthma and discuss currently available add-on type 2 targeted treatments for severe asthma. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

US Specialty Pharmaceutical Trends, Issues and Outlook for NASP

This activity will discuss COVID, Medical claims, telehealth and different specialties. The faculty will discuss where we are now and a deep dive into specialty versus traditional pharmacy and a look ahead to the future. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Utilizing Technology for Patient Communication in Specialty

This activity will discuss ways to identify and implement patient engagement technologies. Methods to assess implementation will also be shared. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Vancomycin Dosing: From Trough to AUC

In this activity, participants will better understand appropriate utilization of AUC-based dosing, including evidence-based support of usage and implementation strategies.

What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1

Ryan Shields and Erin McCreary discuss notable infectious diseases publications from the first half of 2020. SIDP Members visit www.SIDP.org/MbrRate for member pricing.

What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2

Ryan Shields and Erin McCreary discuss notable infectious diseases publications from the first half of 2020. SIDP Members visit www.SIDP.org/MbrRate for member pricing.